Association between HER-۲/Neu overexpression in gastric adenocarcinoma and histopathologic features of tumor in gastrectomy samples: a cross-sectional study in Kerman, Iran

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 125

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JKMU-26-3_001

تاریخ نمایه سازی: 19 دی 1401

Abstract:

Background:In tumoral cells, the HER-۲/Neu is an oncogene and overexpression would result in further membranous proteins. The role of this gene is known in ling and breast cancers. This study was undertaken to determine the HER-۲/Neu overexpression in gastrectomy samples in patients with gastric cancer and its association with tumor histopathology prognostic factors. Methods: This cross-sectional study was conducted among ۴۸ samples of gastric cancer under gastrectomy. The slides were prepared to assess HER-۲/Neu stained by IHC method (Biogenax Kit and DAOK criteria). Statistical analysis was done using SPSS software version ۲۰.۰. Results: Out of ۴۸ cases, ۷۹.۲% were males. The mean age was ۵۹.۹۳ ± ۱۳.۹۵ years and the mean tumor size was ۵.۵ ± ۲.۴۵ cm. Majority of cases were in anthrum and pylor (۴۳.۸%). Lauren class showed a higher frequency of intestinal type (۷۲.۹%). In surgery the majority of cases were found to be in T۳ stage (۸۷.۵%). Her-۲/Neu was positive in ۱۰.۴% of cases and it was negative in ۸۹.۶% of cases. Despite the higher rate of tumors with further expression of HER-۲/Neu in those with a size over ۵ cm and with vascular invasion, there was no significant association between Her-۲/Neu and other variables (P > ۰.۰۵). Conclusion: According to the results of this study, overexpression of HER-۲/Neu in gastric cancer is low (۱۰.۴%) and there is no significant association with other variables. It is suggested that further similar studies with a larger sample size be carried out to definitely determine the association between this marker and prognostic factors.

Authors

Mohammad Mahdi Hayatbakhsh Abbasi

Associate Professor of Internal Medicine , Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Elham Jafari

Assistant Professor, Pathology and stem cells Research Center, Kerman University of Medical Sciences, Kerman, Iran

Mohamad Javad Zahedi

Professor of Internal Medicine ,Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Sodaif Darvish Moghaddam

Professor of Internal Medicine ,Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Nasrin Naghibzadeh Tahami Zarandi

Faculty of medicine , Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, ...
  • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer ...
  • Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: ...
  • Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. ...
  • Correa P. Helicobacter pylori and gastric cancer: state of the ...
  • Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de ...
  • Lastraioli E, Raffaella Romoli M, Arcangeli A. Immunohistochemical biomarkers in ...
  • Normanno N, De Luca A, Bianco C, Strizzi L, Mancino ...
  • Fornaro L, Lucchesi M, Caparello C, Vasile E, Caponi S, ...
  • Gravalos C, Jimeno A. HER۲ in gastric cancer: a new ...
  • Zhang XL, Yang YS, Xu DP, Qu JH, Guo MZ, ...
  • Giuffrè G, Ieni A, Barresi V, Caruso RA, Tuccari G. ...
  • Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, ...
  • Tan M, Yu D. Molecular mechanisms of erbB۲-mediated breast cancer ...
  • Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, ...
  • Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, ...
  • Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW, ...
  • Ross JS, Mulcahy M. HER۲ testing in gastric/gastroesophageal junction adenocarcinomas: ...
  • Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, ...
  • Yan B, Yau EX, Bte Omar SS, Ong CW, Pang ...
  • Ananiev J, Gulubova M, Manolova I, Tchernev G. Prognostic significance ...
  • Jørgensen JT, Hersom M. HER۲ as a prognostic marker in ...
  • Liang JW, Zhang JJ, Zhang T, Zheng ZC. Clinicopathological and ...
  • Gu J, Zheng L, Wang Y, Zhu M, Wang Q, ...
  • Hadi AA, Hindawi AE, Hareedy A, Khalil H, Ashiry RA, ...
  • Seo KW, Jeon T, Kim S, Kim SS, Kim K, ...
  • Sreeram S, Chakraborti S, Naik R, Saha D, Radhakrishnan Y, ...
  • Zhu GJ, Xu CW, Fang MY, Zhang YP, Li Y. ...
  • Lashkarizadeh MR, Bazrafshani MR, Izadi A, Hosseini F. Evaluation of ...
  • Janbabaee G, Naghshvar F, Farazmandfar T, Salehi M, Rashidi M. ...
  • Gurel S, Dolar E, Yerci O, Samli B, Ozturk H, ...
  • Shi HZ, Wang YN, Huang XH, Zhang KC, Xi HQ, ...
  • Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, ...
  • Barros-Silva JD, Leitao D, Afonso L, Vieira J, Dinis-Ribeiro M, ...
  • Grabsch H, Sivakumar S, Gray S, Gabbert HE, Müller W. ...
  • Emadian O, Naghshvar F, Torabizade ZH, Yaseri AR, Khalilian AR, ...
  • Oshima CT, Lanzoni VP, Iriya K, Forones NM. C-erbB-۲ oncoprotein ...
  • Tanner M, Hollmen M, Junttila TT, Kapanen AI, Tommola S, ...
  • Xu CC, Yue L, Wei HJ, Zhao WW, Sui AH, ...
  • Abbasi M, Mobaien A, Majlesi A, Kamalian N, Monsef A. ...
  • Ognjenovic L, Trajkovski G, Gjoshev S, Shumkovski A, Dzambaz D, ...
  • نمایش کامل مراجع